Valion Bio (VBIO) Gross Margin (2021 - 2025)
Valion Bio (VBIO) posted Gross Margin of -99.32% for Q3 2025, down 134.24 percentage points from 34.92% a year earlier and down 162.11 percentage points from the prior quarter.
Powered by 
Analysis
Valion Bio (VBIO) Gross Margin (2021 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2025, Gross Margin at Valion Bio was -58.09%, down 83.80 percentage points year-over-year; for FY2024, it came in at 0.26%, down 24.15 percentage points from FY2023.
- Annual Gross Margin shows a three-year change of +3.28 percentage points (FY2021 to FY2024).
- In prior years, Valion Bio's Gross Margin was 24.40% in FY2023 (+8.15 pp), 16.25% in FY2022 (+19.27 pp) and -3.02% in FY2021.
- Quarterly Gross Margin has run from a low of -132.78% in Q4 2024 to a high of 71.43% in Q1 2025 over five years.
- On a year-over-year basis, Gross Margin increased in three of the last eight quarters, with an average year-over-year change of -26.83 percentage points.
- The strongest year-over-year quarter for Gross Margin in the past five years was Q2 2025, with a gain of 41.36 percentage points; the weakest was Q3 2025, with a drop of 134.24 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was 62.79% (Q2 2025), 71.43% (Q1 2025) and -132.78% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 72.78% |
| 10 | Valion Bio | 130,630.24 | -19.31 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -99.32% |
| Jun 30, 2025 | 62.79% |
| Mar 31, 2025 | 71.43% |
| Dec 31, 2024 | -132.78% |
| Sep 30, 2024 | 34.92% |
| Jun 30, 2024 | 21.43% |
| Mar 31, 2024 | 50.00% |
| Dec 31, 2023 | 1.40% |
| Sep 30, 2023 | 38.30% |
| Jun 30, 2023 | 37.89% |
| Mar 31, 2023 | 30.05% |
| Dec 31, 2022 | 10.54% |
| Sep 30, 2022 | 13.21% |
| Jun 30, 2022 | 23.67% |
| Mar 31, 2022 | 16.36% |
| Dec 31, 2021 | -0.51% |
| Sep 30, 2021 | -9.39% |
| Jun 30, 2021 | -12.31% |
| Mar 31, 2021 | 6.81% |
API Access
Valion Bio Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();